243 related articles for article (PubMed ID: 1507428)
1. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
Kobayashi Y
Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
[TBL] [Abstract][Full Text] [Related]
2. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
Ishii T; Takayama Y; Takase Y; Orikasa Y
Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of MRSA infections].
Inamatsu T
Nihon Naika Gakkai Zasshi; 1992 Oct; 81(10):1662-7. PubMed ID: 1469319
[No Abstract] [Full Text] [Related]
4. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Inoue M; Nonoyama M; Okamoto R; Ida T
Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus.
Watanabe T; Ohashi K; Matsui K; Kubota T
J Antimicrob Chemother; 1997 Apr; 39(4):471-6. PubMed ID: 9145819
[TBL] [Abstract][Full Text] [Related]
7. [MRSA infections in surgery].
Fujita K; Suzuki T; Kato H; Nagamachi Y; Okubo T
Jpn J Antibiot; 1994 Jun; 47(6):813-9. PubMed ID: 8072191
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on methicillin-resistant Staphylococcus aureus (MRSA) infections].
Okumura A; Muraishi Y; Tsuritani S; Sakamoto M; Kazama T; Fuse H; Katayama T
Hinyokika Kiyo; 1993 Dec; 39(12):1157-61. PubMed ID: 8285164
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy of arbekacin on MRSA infections].
Ichiyama S; Shimokata K
Jpn J Antibiot; 1994 Jun; 47(6):731-5. PubMed ID: 8072181
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
[TBL] [Abstract][Full Text] [Related]
11. [Drug resistance of methicillin-resistant Staphylococcus aureus (MRSA) in Japan until 1993].
Hashimoto H
Jpn J Antibiot; 1994 Jun; 47(6):575-84. PubMed ID: 8072165
[TBL] [Abstract][Full Text] [Related]
12. [MRSA].
Hanaki H
Nihon Rinsho; 2001 Nov; 59 Suppl 7():214-22. PubMed ID: 11808124
[No Abstract] [Full Text] [Related]
13. [Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure].
Inaba Y; Hiramatsu K
Nihon Rinsho; 1998 Oct; 56(10):2699-705. PubMed ID: 9796340
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
Kono K; Takeda S; Tatara I; Arakawa K; Tanaka H; Miyake S; Minamikawa H; Hoshino H; Sato M; Hattori F
Jpn J Antibiot; 1994 Jun; 47(6):798-803. PubMed ID: 8072189
[TBL] [Abstract][Full Text] [Related]
15. [Gram-positive cocci (include MRSA)].
Tsuji A
Nihon Rinsho; 1994 Feb; 52(2):359-66. PubMed ID: 8126886
[No Abstract] [Full Text] [Related]
16. [Special issue: Current state of MRSA infections and practical chemotherapy with arbekacin].
Jpn J Antibiot; 1994 Jun; 47(6):561-843. PubMed ID: 8072164
[No Abstract] [Full Text] [Related]
17. Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.
Lee JY; Oh WS; Ko KS; Heo ST; Moon CS; Ki HK; Kiem S; Peck KR; Song JH
J Korean Med Sci; 2006 Apr; 21(2):188-92. PubMed ID: 16614499
[TBL] [Abstract][Full Text] [Related]
18. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of MRSA pneumonia. Niigata Research Group of MRSA.ABK].
Arakawa M; Wada K; Sega H; Yoshikawa H; Honma T; Miyao H; Shimazu Y; Tsukada H; Hoshino S; Sato S
Jpn J Antibiot; 1994 Jun; 47(6):736-40. PubMed ID: 8072182
[TBL] [Abstract][Full Text] [Related]
20. Effect of arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
Yoshikawa Y; Morikawa K; Nonaka M; Torii I
J Infect Chemother; 2004 Oct; 10(5):268-73. PubMed ID: 16163460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
